Tram is an entrepreneurial corporate director and former Fortune 50 C-level Executive with over 25 years of leadership in health innovation and technology-driven industries, regulated and highly disruptive environments across five continents. She is recognized for connecting the dots in the boardroom and bringing fresh international collaboration and market expansion lenses, powered by a diverse global network.The breadth and depth of her experience come from having served in executive, advisory, and board leadership positions for varying-sized organizations, public and private, family businesses, and startups. As an inclusive leader, she has been interviewed and featured in four chapters of “The 5 Disciplines of Inclusive Leaders: Unleashing the Power of All of Us,” a book released by Korn Ferry in 2020.
Tram currently serves on profit and nonprofit advisory boards, public and private companies dedicated to advancing healthcare, finance, and data security with blockchain and AI technology. She has also engaged as an Independent Director Affiliate member of the Luxembourg Private Equity Association adding governance insights to Private Equity-backed portfolio companies. As the founder and current CEO of her private investment holding Vitanlink, Tram identifies, co-invests, and co-develops emerging growth ventures in partnerships with private equity and single-family offices as an advisor, board member and investor.
PRIOR BOARD EXPERIENCE
Tram previously served as a member of the board of directors with QuantsUnited, an AI-powered wealth tech company. She was instrumental in recruiting a new CEO, repositioning the company from a B2B to a B2C AI product model, and led the company’s board decisions during the acquisition and transition into Synthetic Neural Labs Inc in 2021.
She served as an independent lead board director for another emerging growth AI venture DreamUp Vision, where she helped the board connect to and acquire a high-profile acquirer lead in a 4-month timeframe.
Tram added value as a member of the EMEA Executive Board for Welch Allyn, owned since 2021 by Baxter International Inc (NYSE: BAX). She transformed the market, products, and channel models and closed an initial acquisition of the French entity by a European distributor that paved the way for future acquisitions.
Tram began her career as an auditor with EY, where she opened key offices in Vietnam and Cambodia before moving to J&J (NYSE: JNJ) Ortho-Clinic Diagnostics. She was awarded twice the Johnson & Johnson standards of leadership awards and she assumed increasing levels of P/L accountability, ultimately serving as a member of the EMEA management board. She expanded the international footprint for the $3 Billions JNJ’s IVD division.
Tram holds an MBA from McGill University. She is currently completing her Master of Laws in International Financial and Commercial Law from King’s College London. Tram is a US Certified Public Accountant [CPA New Hampshire State Board of Accounting] , Certified in Private Company Governance and
Private Equity Portfolio Company Governance with US PDA and Non-Executive Director Certified with the Financial Times UK. Based in Paris, she is a fluent in French, Vietnamese, German, and English.
Founding Vitanlink and leading each Portfolio Company to success
(I) AI health company selected top 5 in SXSW out of 2000 contenders, received a transaction offer $5 M from listed Fortune 100 MedTech and 20% stake within 4-month of incorporation.
(II) Award-winning co-founded AI fintech company sold to US holding and subsequent oversight of the new organization's global ecosystem of 6 continents and risks post-sale
Regional Distribution Model change for a $2B family-owned business, paving the way to the future acquisition by a buyer.
Enabled $70M opportunities detection for J&J OCD in China
PRIVATE & PUBLIC BOARDS
Advisory Member, TenderHut SA (WSE: THG)
Former Executive Member, Johnson & Johnson OCD Regional EMEA Board (NYSE: JNJ)
Chair, Vitanlink, France
Advisory Member, The Sabi, Netherlands
Advisory Member, Nium.io, Luxembourg
Former Advisory Member, Thais Health Inc. US
Former Advisory Member, Droon France
Former Director, AI Fintech QuantsUnited
Former Director DreamUp Vision, France
Former Executive Board Member, WelchAllyn Inc Regional EMEA Board, US family-owned business
BOARD ASSETS & SECTORS
International Channel & Market Expansion
Corporate & Advisory Board Governance
Revenue & EBITDA growth
LPEA Luxembourg Private Equity Association
BCFL Business Club France Luxembourg
Ascend Pan-Asian Leadership Network
Boardex Ambassador Club
IPEL Ivy Plus European Leaders
NACD National Association of Corporate Directors
PDA Private Directors Association
PDA New York Chapter Education Committee Member,
Diversity Equity and Inclusion Advocate NY & National PDA
AI Deep Learning
AI Machine Learning
The word around town
Co-Founder & CEO
Thaïs Health Inc
'Tram brings a fresh differentiated perspective in collaborations with fast access to the right people, companies in target growth markets'
Washington DC, US, 2017
Single Family Office
'When Tram Trinh sits on a Board she is always active in providing solutions, ideas to support companies’ growth.
I highly recommend her'
Paris, France, 2020
Health Futures Forum
'Tram is an inspiring thought leader and an excellent facilitator'
London, UK, 2020
Board Member, Former Corporate Senior VP
'Tram has all the personal values that I live by: passion for what she does, full commitment with truth and reality, integrity, loyalty, [..] and a serving leadership vocation'
Lausanne, Suisse, 2020
Innovation Officer, Embassy of Canada
'Not only she is passionate about developing entrepreneurial communities [..] but also she is excellent at leveraging her network to generate meaningful opportunities' Paris, France, 2017
Managing Director, Rouge International
'Tram’s dedication to developing, encouraging, and providing exposure for her portfolio companies as an entrepreneur, investor, advisor, and board member is unparalleled' [..]
Hong Kong, HK SAR, 2022
Hospital MD, President
'I have been working with Tram for more than ten years during which we shared complex situations related to the healthcare sector. What I always appreciate is her ability to think globally and locally [..]'
Bordeaux, France, 2022